TERMS & CONDITIONS FOR PURCHASING INJECTABLES & MEDICATIONS :
1- REGULATIONS ON PURCHASE OF INJECTABLES & MEDICATIONS VARY FROM
STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY
WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE.
2- INJECTABLES & MEDICATIONS WOULD BE SOLD ONLY TO QUALIFIED
CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES ,
DENTAL OFFICES , HEALTH CARE PROVIDERS , .... ) WITH VALID MEDICAL
LICENSE.
3- ORDERS INCLUDING PURCHSE OF INJECTABLES & MEDICATIONS WOULD BE
PROCESSED AFTER VERIFICATION OF PURCHASER'S VALID MEDICAL LICENSE TO BE
EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO
323-782-0985 )
Manufacturer # 33332001701
Brand Afluria® 2017 - 2018
Manufacturer Seqirus USA Inc
Application Flu Vaccine
Container Type Prefilled Syringe
Dosage Form Injection
Generic Drug Code 43467
NDC Number 33332-0017-01
Storage Requirements Requires Refrigeration
Strength 45 mcg / 0.5 mL
Type Intramuscular
User Indicated For People 5 Years of Age and Above
Volume 0.5 mL
Features
AFLURIA is an inactivated influenza vaccine indicated
for active immunization against influenza disease caused by influenza
virus subtypes A and type B present in the vaccine
AFLURIA is approved for use in persons 5 years of age and older
AFLURIA is standardized according to USPHS requirements for the
2017-2018 influenza 409 season and is formulated to contain 45 mcg
hemagglutinin (HA) per 0.5 mL dose in the 410 recommended ratio of 15
mcg HA for each of the three influenza strains recommended for the 411
2017-2018 Northern Hemisphere influenza season: A/Singapore/GP1908/2015
(H1N1), IVR-412 180A, A/Hong Kong/4801/2014 (H3N2), NYMC X-263B, and
B/Brisbane/46/2015